5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts
Key Takeaways
- Adjunctive therapies should be selected only after wound etiology, wound bed status, contraindications, and facility policy are considered.
- Electrical stimulation and ultrasound questions usually test indication, scope, implanted-device or malignancy cautions, patient tolerance, and reassessment.
- Topical adjuncts do not replace cleansing, moisture balance, debridement decisions, pressure control, or infection workup.
- The exam trap is treating an adjunct as a universal rescue for a stalled wound without first asking why healing stalled.
Adjunctive therapy selection
The WCC Treatment domain includes adjunctive therapies, but the exam does not reward a device-first mindset. A therapy is advanced only if it is matched to the right wound problem, used within professional scope, documented, and reevaluated. The official WCC credential is for licensed practitioners working under state practice acts and employer guidelines, so scope is part of every adjunctive therapy question.
Adjuncts commonly appear when a wound is stalled despite basic wound bed preparation. Examples include electrical stimulation, therapeutic ultrasound, contact layers, topical agents, cellular or tissue-based products, and biologically active dressings. Study these as categories, not as promises of healing. The WCC candidate should first ask whether perfusion, pressure, infection, edema, nutrition, glycemic control, medication effects, or adherence barriers are blocking progress.
| Adjunct category | Exam purpose | Safety and scope check |
|---|---|---|
| Electrical stimulation | May support selected chronic wound healing programs | Screen for pacemaker or implanted device concerns, sensation, pregnancy precautions, malignancy site, and policy |
| Ultrasound therapy | May be used in selected tissue-healing protocols | Confirm order, trained operator, treatment area, pain, and contraindication signals |
| Topical antimicrobial | May reduce local bioburden when indicated | Avoid indefinite use without reassessment or infection workup |
| Collagen or matrix dressing | May support wound bed when moisture and cause are controlled | Do not place over unmanaged necrosis or heavy uncontrolled exudate |
| Cellular or tissue-based product | May be considered for selected nonhealing wounds | Check eligibility criteria, wound bed readiness, payer rules, and documentation |
Applied WCC scenario guidance: a venous leg ulcer has been dressed with the same foam for weeks, but measurements show no progress and edema is uncontrolled. The best next answer is not to add a high-cost matrix product immediately. The candidate should reassess compression appropriateness, vascular status, exudate, infection signs, nutrition, adherence, and referral needs before selecting an adjunct.
Electrical stimulation and ultrasound questions often hide contraindication clues. Implanted electrical devices, impaired sensation, malignancy in the treatment area, untreated osteomyelitis concern, pregnancy-related treatment areas, active bleeding, or inability to report discomfort can change the answer. Do not invent absolute rules beyond the stem, but choose the option that pauses and checks policy when safety data are incomplete.
Topical adjuncts can also be traps. A topical antimicrobial may be useful when local infection or high bioburden is suspected, but prolonged routine use can damage healthy cells or mask failure to treat the cause. A growth factor or tissue product can fail if placed on a dry necrotic wound, an ischemic wound, or an ulcer still being traumatized by pressure.
Documentation should link the adjunct to a measurable goal. Record why it was chosen, baseline wound characteristics, contraindication review, patient education, tolerance, product or device used, and the planned reevaluation point. The WCC exam favors measurable reassessment because Re-Evaluation is its own official domain.
Exam trap: the most advanced-sounding answer is not automatically correct. When the stem says new odor, fever, increasing pain, ischemic signs, or undermining, the best action may be infection or vascular workup and referral rather than adding an adjunct. Advanced therapy is not a substitute for diagnosis, source control, or prevention.
A stalled venous ulcer has persistent edema and inconsistent compression use. Which WCC action is best before adding an expensive topical matrix product?
Which finding is the strongest reason to pause before electrical stimulation therapy?
What is the key exam trap with topical antimicrobial adjuncts?